BDBM423408 US11753373, Compound A-5-c::WO2005113580-Ex-01

SMILES COc1cccc2[nH]c(cc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C(=O)CCl

InChI Key InChIKey=HYLDYCNHHSWPDN-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 423408   

TargetReplicase polyprotein 1ab(SARS-CoV)
Pfizer

WIPO
LigandPNGBDBM423408(WO2005113580-Ex-01 | US11753373, Compound A-5-c)
Affinity DataEC50:  1.00E+4nMAssay Description:Protection from SARS Infection: Neutral Red Endpoint The ability of compounds to protect cells against infection by the SARS coronavirus is measured ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2005113580

TargetReplicase polyprotein 1ab(2019-nCoV)
Acea Therapeutics

US Patent
LigandPNGBDBM423408(WO2005113580-Ex-01 | US11753373, Compound A-5-c)
Affinity DataIC50: 359nMAssay Description:Mpro activity was measured according to the manufacturer's protocol (BPS Biosciences, cat #78042-2) in 384-well plates. The included recombinant un-t...More data for this Ligand-Target Pair
In DepthDetails
US Patent